A COMPARISON OF HTA RECOMMENDATIONS ISSUED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) IN POLAND AND THE SCOTTISH MEDICINES CONSORTIUM (SMC)

被引：0

作者：

Kolasa, K. ^{[1
]}

机构：

[1] AstraZeneca, Sodertalje, Sweden

来源：

VALUE IN HEALTH | 2009年 / 12卷 / 07期

关键词：

D O I：

10.1016/S1098-3015(10)74223-6

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A250 / A250

页数：1

共 50 条

[1] A COMPARISON OF HTA RECOMMENDATIONS ISSUED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AHTAPOL) AND NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) IN THE UK - CONSIDERATION OF SOCIAL IMPLICATIONS IN HTA
Ceglowska, U.
Kolasa, K.
Hermanowski, T.
VALUE IN HEALTH, 2011, 14 (07) : A355 - A355
[2] WHAT DETERMINES THE RECOMMENDATIONS ISSUED BY POLISH HEALTH TECHNOLOGY AGENCY (AHTAPOL)?
Niewada, M.
Polkowska, M. A.
Jakubczyk, M.
Golicki, D.
VALUE IN HEALTH, 2011, 14 (07) : A241 - A241
[3] A COMPARISON OF HTA RECOMMENDATIONS FOR CANCER TREATMENT TECHNOLOGIES PUBLISHED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) AND NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE)
Kiljan, A.
Kolasa, K.
Hermanowski, T.
VALUE IN HEALTH, 2010, 13 (07) : A280 - A281
[4] THE INFLUENCE OF COST-EFFECTIVENESS ISSUES OF THE APPRAISED ORPHAN DRUGS ON RECOMMENDATIONS OF AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AHTAPOL)
Ofierska-Sujkowska, G.
Jagodzinska-Kalinowska, K.
Matusewicz, W.
VALUE IN HEALTH, 2011, 14 (03) : A21 - A21
[5] HTA PROCEDURES IN DRUG REIMBURSEMENT PROCESS IN POLAND. EVOLUTION OF RECOGNITION THE ROLE OF AGENCY OF HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) BY POLICY MAKERS
Krol, Z. J.
Matusewicz, W.
Musialowicz, A.
VALUE IN HEALTH, 2009, 12 (03) : A202 - A203
[6] A review of Health Technology Assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policymaking processes in Poland
Kolasa, Katarzyna
Schubert, Sebastian
Manca, Andrea
Hermanowski, Tadeusz
HEALTH POLICY, 2011, 102 (2-3) : 145 - 151
[7] LOW EFFICACY OF INNOVATIVE DRUGS AS A KEY FACTOR OF NEGATIVE RECOMMENDATIONS ISSUED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AOTM) IN 2011
Ofierska-Sujkowska, G.
Jagodzinska-Kalinowska, K.
Matusewicz, W.
Pasierski, T.
VALUE IN HEALTH, 2012, 15 (04) : A26 - A26
[8] APPLICATION OF THRESHOLD VALUE FOR COST-EFFECTIVENESS IN RECOMMENDATIONS ISSUED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND FOR CANCER DRUG TECHNOLOGIES
Zawodnik, A.
Matusewicz, W.
VALUE IN HEALTH, 2014, 17 (07) : A660 - A660
[9] REVIEW OF HTA RECOMMENDATIONS FOR DRUG THERAPIES IN POLAND ISSUED FROM SEPTEMBER 6, 2007 UNTIL OCTOBER 28, 2008 BY THE CONSULTATIVE COUNCIL (APPRAISAL COMMITTEE) OF AHTAPOL IN POLAND
Kolasa, K.
VALUE IN HEALTH, 2009, 12 (03) : A94 - A94
[10] THE INFLUENCE OF RECOMMENDATIONS RELATED TO CARDIOVASCULAR DRUGS ISSUED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AOTM) IN YEARS 2005-2012 FOR THE REIMBURSEMENT DECISIONS
Ofierska-Sujkowska, G.
Jagodzinska-Kalinowska, K.
Matusewicz, W.
VALUE IN HEALTH, 2013, 16 (03) : A296 - A297

← 1 2 3 4 5 →